phosphoenolpyruvate has been researched along with Disease Models, Animal in 7 studies
Phosphoenolpyruvate: A monocarboxylic acid anion derived from selective deprotonation of the carboxy group of phosphoenolpyruvic acid. It is a metabolic intermediate in GLYCOLYSIS; GLUCONEOGENESIS; and other pathways.
phosphoenolpyruvate : A monocarboxylic acid anion resuting from selective deprotonation of the carboxy group of phosphoenolpyruvic acid.
phosphoenolpyruvic acid : A monocarboxylic acid that is acrylic acid substituted by a phosphonooxy group at position 2. It is a metabolic intermediate in pathways like glycolysis and gluconeogenesis.
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Oleic acid-induced hypoxemia is an animal model of acute respiratory distress syndrome (ARDS)." | 3.72 | Preventive effect of phosphoenolpyruvate on hypoxemia induced by oleic acid in Guinea pigs. ( Golbidi, S; Hamasaki, N; Irie, T; Irikura, M; Moriuchi, H; Yang, C, 2003) |
| "Gluconeogenesis increases in diabetic nephropathy (DN), escalating fasting and postprandial glucose levels." | 1.91 | PCK1 Protects against Mitoribosomal Defects in Diabetic Nephropathy in Mouse Models. ( Hasegawa, K; Sakamaki, Y; Tamaki, M; Wakino, S, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Hasegawa, K | 1 |
| Sakamaki, Y | 1 |
| Tamaki, M | 1 |
| Wakino, S | 1 |
| Jiang, W | 1 |
| Han, X | 1 |
| Wang, Q | 1 |
| Li, X | 1 |
| Yi, L | 1 |
| Liu, Y | 1 |
| Ding, C | 1 |
| Marroquí, L | 1 |
| Batista, TM | 1 |
| Gonzalez, A | 1 |
| Vieira, E | 1 |
| Rafacho, A | 1 |
| Colleta, SJ | 1 |
| Taboga, SR | 1 |
| Boschero, AC | 1 |
| Nadal, A | 1 |
| Carneiro, EM | 1 |
| Quesada, I | 1 |
| Golbidi, S | 1 |
| Moriuchi, H | 1 |
| Yang, C | 1 |
| Irikura, M | 1 |
| Irie, T | 1 |
| Hamasaki, N | 1 |
| Knight, KR | 1 |
| Dvir, E | 1 |
| Kawabata, H | 1 |
| Coe, SA | 1 |
| Macleod, AM | 1 |
| O'Brien, BM | 1 |
| van Berkel, TJ | 1 |
| Koster, JF | 1 |
| Hülsmann, WC | 1 |
| Hanson, RW | 1 |
7 other studies available for phosphoenolpyruvate and Disease Models, Animal
| Article | Year |
|---|---|
PCK1 Protects against Mitoribosomal Defects in Diabetic Nephropathy in Mouse Models.
Topics: Albuminuria; Animals; Collagen Type IV; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; | 2023 |
Vibrio parahaemolyticus enolase is an adhesion-related factor that binds plasminogen and functions as a protective antigen.
Topics: Adhesins, Bacterial; Animals; Antigens, Bacterial; Biotransformation; Cell Membrane; Cloning, Molecu | 2014 |
Functional and structural adaptations in the pancreatic α-cell and changes in glucagon signaling during protein malnutrition.
Topics: Animals; Calcium Signaling; Cells, Cultured; Diet, Protein-Restricted; Dietary Proteins; Disease Mod | 2012 |
Preventive effect of phosphoenolpyruvate on hypoxemia induced by oleic acid in Guinea pigs.
Topics: Animals; Blood Gas Analysis; Capillary Permeability; Carbon Dioxide; Coloring Agents; Disease Models | 2003 |
Factors involved in salvaging ischaemic rabbit skin flaps: ATP and free radicals but not thromboxane.
Topics: Adenosine Triphosphate; Animals; Disease Models, Animal; Imidazoles; Phosphoenolpyruvate; Rabbits; R | 1989 |
Some kinetic properties of the allosteric M-type pyruvate kinase from rat liver; influence of pH and the nature of amino acid inhibition.
Topics: Adenosine Triphosphate; Alanine; Allosteric Regulation; Animals; Binding Sites; Disease Models, Anim | 1973 |
The choice of animal species for studies of metabolic regulation.
Topics: Acidosis; Animals; Cattle; Cytosol; Disease Models, Animal; Dogs; Evaluation Studies as Topic; Fatty | 1974 |